Smoking Cessation: A Practical Overview of Pharmacotherapy Joseph Saseen, Pharm.D., FCCP, BCPS Professor University of Colorado

Slides:



Advertisements
Similar presentations
Do you think smokers can quit smoking?
Advertisements

Nicotine Addiction Pharmacy Practice II Winter 2005.
STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Treatment of Tobacco Dependence in 2012 J. Taylor Hays, MD Professor of Medicine Associate Director Nicotine Dependence Center Mayo Clinic Rochester, MN.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Key Public Health issues of smoking Passive smoking in home, car, workplace, restaurants etc. Self- induced disease and cost of smoking related diseases.
Nicotine Replacement Therapy: Administration and Overview Barbara Hart, MPA and Claudia Lechuga, MS Bronx BREATHES T: (718) E:
All About Smoking Cessation Going for the 3 Increases: Increase in Health, Increase in Happiness & Increase in Energy Strategies for Success in Health.
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Treating Nicotine Dependence in Patients with Addictive Disorders Eric Heiligenstein, M.D. Director of Psychiatry University Health Services University.
Ken Wassum & Abigail Halperin Session 13: Behavioral Counseling and Pharmacotherapy 09/14/2011.
ASSISTING PATIENTS with TOBACCO CESSATION: A Behavioral Approach.
Pharmacotherapy for the Treatment of Nicotine Dependence Donna Shelley, MD, MPH, Columbia University Mailman School of Public Health
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
© Business & Legal Reports, Inc Alabama Retail is committed to partnering with our members to create and keep safe workplaces. Be sure to check out.
Tobacco Facts Causes illness and death But it’s avoidable Linked to: Multiple cancers Heart disease Stroke Complications of pregnancy Chronic obstructive.
Center for Tobacco Research and Intervention University of Wisconsin Medical School Transdisciplinary Tobacco Use Research Centers Treating Tobacco Use.
1 Tobacco Road: How to Navigate the Tricky Corners, Detours and Pot Holes of Tobacco Cessation Presented By: Bill Byron.
The Ohio Partners for Smoke-Free Families 5A’s
Quitting Smoking How to stop smoking … for good!.
Smoking Cessation Presented by Integrated Behavioral Health.
Insert your name and program name here
Welcome to the Beat the Pack Program Program Launch: Reasons to Quit.
Smoking. { Why Do People Start Smoking? -seem mature -independent -popularity -weight management -media influence -family -curiosity.
Clinical aspects of smoking cessation Jean-Pierre Zellweger, MD Swiss Lung Association and Int. Union against TB and Lung Disease (The Union)
2010 PHS Clinical Practice Guidelines: Smoking Cessation CDR Sherri Yoder PharmD, BCPS, CER Program Principal Consultant Indian Health Service USPHS COA.
1 Smoking Cessation Presented by CIGNA Employee Assistance Program Copyright 2008 CIGNA HealthCare – Confidential & Privileged – Not for Distribution.
Nicotine-related disorders Answers obtained from DSM-IV-TR and the AJP Supplement of August, 2006, on substance abuse As of 1Sep08.
Quit Information Seminar. Aims of session To: help you to understand why people smoke provide information about quitting methods and products discuss.
Smoking Cessation: the pharmacotherapeutic and non-pharmacotherapeutic approaches to addictive behavior Andrea C. McKean February 22, 2007.
Tobacco Use and Dependence Guideline Update 2011 Annual South Texas Oral Health Network Summer Meeting August 5 th, Carlos Roberto Jaén, MD, PhD,
Treating Tobacco Dependence Ask your patients about tobacco use Act to help them quit.
Link Between Secondhand Smoke and Growth in CF Patients by: Pulmonary Medicine and Infectious Diseases at Nationwide Children’s Hospital.
QUITTING SMOKING… WHY YOU SHOULD DROP THE HABIT AND HOW YOUR LIFE WILL IMPROVE IF YOU DO BY: BRADYN MUSICH.
PHARMACOTHERAPY for SMOKING CESSATION
1 Smoking Cessation: What works and why… A Medical Model Stephen I Rennard University of Nebraska Florianopolis, Brazil October 2009.
TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
Tobacco Cessation Strategies and Resources: Epidemiology, Evidence and Availability May 29, 2013 The National Tobacco-Free College Campus Initiative: Building.
July 2006 Treating Tobacco Use and Dependence. Learning Objectives At the end of this session you should understand: The impact of tobacco dependence.
Effects of a combination of varenicline and nicotine patch on post-quitting urges to smoke Katie Myers Smith BSc MSc CPsychol Research Fellow Wolfson Institute.
Living Tobacco-Free It really is possible!. Agenda Statistics and mortality risks Health risks Benefits of quitting Ways to quit.
Better Health. No Hassles. Nicotine Dependence Addiction to tobacco products. Nicotine produces physical and mood-altering effects that are temporarily.
Journal #15 What does stimulant mean? What does Carcinogen mean?
NICOTINE LOZENGE Commit (GlaxoSmithKline); generics Nicotine polacrilex formulation Delivers ~25% more nicotine than equivalent gum dose Sugar-free, mint.
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
Types of help Available NHS Stop Smoking Services Nicotine Replacement Therapy (NRT) Other Pharmacological Treatments (non nicotine) Alternative Therapies.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
Smoking. Why people smoke and find it difficult to stop Smoking is an addictive habit. It is associated with strong cravings, dependency, tolerance, and.
Conclusions and Awards
Three Individual Choices To Improve Your Health
Smoking Cessation Medication
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
Meta-analysis of Effectiveness of First-Line Smoking Cessation Pharmacotherapies 6 Months After Quitting Medication Estimated OR (95% CI) Est. abstinence.
Why and How to Quit Smoking
Tobacco Cessation.
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
Tobacco Cessation Guidelines for COPD
Treating Tobacco Dependence
Nicotine Dependence and Treatment
Smoking cessation Felix K. Karthik.
ABCs of Behavioral Support
Mini Lesson #1 – Smoking Cessation
Tobacco Cessation for Primary Care Providers
Presentation transcript:

Smoking Cessation: A Practical Overview of Pharmacotherapy Joseph Saseen, Pharm.D., FCCP, BCPS Professor University of Colorado

Learning Outcomes ● Apply recommendations from guidelines to customize clinical interventions to patients who use tobacco ● Compare and contrast advantages and disadvantages of various tobacco cessation pharmacotherapy products to

U.S. Department of Health and Human Services: Public Health Service (May 2008) Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update f

Potential Health Benefits of Smoking Cessation Time After Smoking 20 min BP, HR, peripheral circulation improve 24 hrs CO levels drop 48 hrs Nicotine eliminated; taste and smell improve 2-12 wks Lung function can improve 30% 3-9 mo SOB and coughing decrease 1 yr Risk of MI reduced 50% 10 yrs Risk of lung cancer reduced 50% 15 yrs Risk of MI and stroke reduce to level of nonsmoker

Nicotine Stimulates Dopamine Release ● High nicotine levels achived in 11 seconds from inhalation Nicotine and Tobacco Research 1999;1:s121-s125

10 Key Guideline Recommendations 1.Repeated intervention and multiple attempts 2.Identify and document tobacco use status and treat every tobacco user 3.Treatments are effective: counseling and medications 4.Brief treatment is effective 5.Counseling is important: practical and social support f

10 Key Guideline Recommendations 6.Medications should be used whenever possible 7.Combination of counseling and medication more effective than either alone 8.Telephone quitline counseling is effective 9.Use motivational treatment if patients unwilling to quit 10. Insurance plans should include counseling and medication coverage f

The “5 A’s” Model f

Meta Analysis 2008 (n=18 studies) TreatmentArms (#) Estimated Odds Ration (95% CI) Estimated Abstinence Rates (95% CI) Medication Alone Medication and Counseling 391.4( )27.6 ( ) 0-1 Sessions plus Medication Sessions plus Medication 61.4 ( )28.0 ( ) 4-8 Sessions plus Medication ( )26.9 ( ) > 8 Sessions plus Medication 91.7 ( )32.5 ( ) f

First Line Medications Nicotine Replacement ●Nicotine gum ●Nicotine inhaler ●Nicotine lozenge ●Nicotine nasal spray ●Nicotine patch Oral Agents ●Bupropion SR ●Varenicline f

Nicotine Gum Advantages ●May satisfy oral cravings ●May delay weight gain ●Patients can titrate therapy to manage withdrawal symptoms Disadvantages ●Gum chewing may not be socially acceptable ●May stick to dental work and dentures ●Proper chewing technique (Chew/Park) needed to minimize adverse effects ●Cannot eat or drink 15 minutes before or while using the nicotine gum

Nicotine Inhaler Advantages ●Patients can easily titrate therapy to manage withdrawal symptoms ●Mimics the hand-to- mouth ritual of smoking Disadvantages ●Initial throat or mouth irritation (in first week) ●Cartridges should not be stored in conditions >86 o F or <59 o F ●Patients with underlying bronchospastic conditions should use with caution

Nicotine Lozenge Advantages ●May satisfy oral cravings ●Easy to use and conceal ●Patients can titrate therapy to manage withdrawal symptoms Disadvantages ●Gastrointestinal side effects (nausea, hiccups, heartburn) may be bothersome ●Must allow slow dissolution for minutes (no chewing) ●Should not eat or drink for 15 minutes before or while using the nicotine lozenge

Nicotine Nasal Spray Advantages ●Dose can be easily titrated to rapidly manage withdrawal symptoms Disadvantages ●Initial nasal or throat irritation can be bothersome (may last up to 3 weeks) ●Higher dependence potential relative to other NRT formulations ●Patients with chronic nasal disorders (e.g., rhinitis, polyps, sinusitis) or severe reactive airway disease should not use

Nicotine Patch Advantages ●Steady-state nicotine levels are achieved throughout the day ●Easy to use and conceal ●Fewer compliance issues are associated with the patch Disadvantages ●Patients cannot titrate dose ●Allergic reactions to the adhesive may occur ●Patients with underlying dermatologic conditions (e.g., psoriasis, eczema, atopic dermatitis) should not use the patch

Bupropion SR (Zyban) Advantages ●Oral formulation given BID that is easy to use ●May be beneficial for patients with coexisting depression ●Initiated before quit date ●No risk of nicotine toxicity if patient continues to smoke Disadvantages ●Increases seizure risk ●Several contraindications and precautions that may preclude use ●Side effects of insomnia and dry mouth

Varenicline (Chantix) Advantages ●Oral formulation given BID that is easy to use ●Initiate before quit date ●New mechanism of action for persons who previously failed using other medications Disadvantages ●May induce nausea in up 1/3 of patients (need to titrate) ●Post-marketing surveillance data stimulated FDA warning

Varenicline (Chantix): Package Insert Update WARNINGS and PRECAUTIONS Serious neuropsychiatric symptoms have occurred in patients being treated with CHANTIX. Some cases may have been complicated by the symptoms of nicotine withdrawal in patients who stopped smoking; however, some of these symptoms have occurred in patients who continued to smoke. All patients being treated with CHANTIX should be observed for neuropsychiatric symptoms including changes in behavior, agitation, depressed mood, suicidal ideation and suicidal behavior.

Varenicline (Chantix): FDA Alert February 1, 2008 Recommendations and Considerations for Healthcare Professionals ● Monitor all patients taking Chantix for serious neuropsychiatric symptoms ● Serious psychiatric illness (e.g., schizophrenia, bipolar, major depressive disorder) may worsen ● Consider these safety concerns and alert patients about these risks

Varenicline (Chantix): FDA Alert February 1, 2008 Information for the patient ● Report any history of psychiatric illness prior to starting Chantix ● Be alert to changes in mood and behavior ● Immediately report changes in mood and behavior ● Vivid, unusual, or strange dreams may occur Medication Guide (5/16/08) ●

Monotherapy TreatmentArms (#) Estimated Odds Ratio (95% CI) Estimated Abstinence Rates (95% CI) Placebo Nicotine Gum 6-14 wks > 14 wks ( ) 2.2 ( ) 19.0 ( ) 26.1 ( ) Nicotine Inhaler62.1 ( )24.8 ( ) Nicotine Nasal42.3 ( )26.7 ( ) Nicotine Patch 6-14 wks >14 wks High-dose (>25mg) ( ) 1.9 ( ) 2.3 ( ) 23.4 ( ) 23.7 ( ) 26.5 ( ) Bupropion SR262.0 ( )24.2 ( ) Varenicline (2 mg/d)53.1 ( )33.2 ( ) f

Combination Pharmacotherapy TreatmentArms (#) Estimated Odds Ratio (95% CI) Estimated Abstinence Rates (95% CI) Nicotine Patch (>14 wk) + ad lib Nicotine Gum/Spray 33.6 ( )36.5 ( ) Nicotine Patch + Nicotine Inhaler 22.2 ( )25.8 ( ) Nicotine Patch + Bupropion SR 32.5 ( )28.9 ( ) ●These combinations are considered “effective” according to guidelines f

Cost of Pharmacotherapy

Bottom Line: Pharmacotherapy for Smoking Cessation All smokers trying to quit should be offered medication…. except when contraindicated or for specific populations for which there is insufficient evidence of effectiveness: Pregnant women Smokeless tobacco users Light smokers Adolescents f

Plethora of Resources ● CO Quitline ( ● Fixnixer ( ● Become an Ex ( ● My Last Dip ( ● Cigarette is Dead ( ● Quit Doing it Labs ( ● Raise Smoke Free Kids (

Quit Tips ●Make a quit plan. Pick a date and make a list of reasons you want to quit. ●Prepare for your quit date. This means getting rid of all tobacco-related items, such as ashtrays, lighters and matches. ●Ask your family and friends to support you in your quit attempt. Tell them your quit date and ask them to be supportive and understanding. ●Keep a picture of your loved ones. Tape a message to the picture that reminds you that you are quitting for them. Look at the picture and read the message anytime you have an urge to smoke. ●When you feel an urge to reach for a cigarette, try taking a walk, playing with your kids or running up and down the stairs instead of lighting up. ●For the first few days after you quit smoking, spend as much free time as possible in public places where smoking is not allowed. ●Reward yourself when you reach milestones in your quit attempt, such as buying yourself a new book or treating yourself to a nice dinner with a supportive friend. ●Keep healthy snacks, gum, mints and toothpicks around, and drink plenty of water. ●Try to avoid people, places or other trigger habits you typically associate with smoking. ●Take deep, slow breaths and imagine your lungs filling with clean, fresh air. ●Create a smoke-free rule for your home and car. Smoke-free environments can support you in the quitting process. ●Don´t give up. Most people have to try several times to quit smoking. You can do it.